Doctor profile · Federal record
Dr. Gottfried Konecny, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Los Angeles, CA
- NPI 1427190115
- Accepts Medicare
- MIPS 84.9 / 100 · 2023
- 37 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 UCLA Medical Plz Ste 550
Los Angeles, CA 900246998
(310) 206-1214 - Mailing address
-
5767 W Century Blvd Ste 400
Los Angeles, CA 900455631
Credentials & registration
- NPI registered
- February 2007 — 19 yrs on file
- Profile last updated
- August 5, 2019
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A124261
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427190115. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
28,913
Distinct HCPCS
10
Medicare allowed
$1,047,486
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 14,800 | 18 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 6,300 | 18 | $0 | |
Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 4,401 | 13 | $28 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 730 | 24 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 640 | 24 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 418 | 105 | $141 | |
J7050 |
Infusion, normal saline solution, 250 cc | 334 | 70 | $1 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 230 | 80 | $8 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 220 | 66 | $155 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 204 | 15 | $0 |
In context: peer comparison
Among 50 peers in this city , average services per provider: 1,244. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$75,121
Transactions
48
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 31 | $41,190.90 | |
| AstraZeneca Pharmaceuticals LP | 4 | $14,911.55 | |
| ImmunoGen, Inc. | 3 | $5,694.51 | |
| Merck Sharp & Dohme LLC | 4 | $5,174.92 | |
| GlaxoSmithKline, LLC. | 2 | $4,839.30 | |
| Genmab U.S., Inc. | 3 | $3,301.08 | |
| ARRAY BIOPHARMA INC | 1 | $8.70 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
269
Patients
24
Total drug cost
$988,324
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 27 | 11 | $521 |
| Ondansetron Hcl | Generic | 26 | 13 | $339 |
| Dexamethasone | Generic | 22 | 0 | $627 |
| Eliquis (Apixaban) | Brand | 22 | 0 | $13,009 |
| Anastrozole | Generic | 21 | 0 | $367 |
| Ibrance (Palbociclib) | Brand | 19 | 0 | $292,482 |
| Prednisolone Acetate | Generic | 19 | 0 | $1,300 |
| Prochlorperazine Maleate | Generic | 18 | 0 | $347 |
| Lenvima (Lenvatinib Mesylate) | Brand | 15 | 0 | $353,320 |
| Zejula (Niraparib Tosylate) | Brand | 15 | 0 | $321,363 |
Hospital affiliations
Frequently asked questions
What is Dr. Gottfried Konecny's medical specialty?
Dr. Gottfried Konecny practices Hematology & Oncology Physician in Los Angeles, CA.
Where does Dr. Gottfried Konecny practice?
Dr. Gottfried Konecny practices at 100 UCLA Medical Plz Ste 550, Los Angeles, CA 900246998. Office phone: 3102061214.
What is Dr. Gottfried Konecny's NPI?
Dr. Gottfried Konecny's National Provider Identifier (NPI) is 1427190115, issued by NPPES.
Does Dr. Gottfried Konecny accept Medicare assignment?
Yes. Dr. Gottfried Konecny accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gottfried Konecny commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS Q5118). Source: CMS Medicare Physician & Other Practitioners file.